tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 171 are a BUY (90.96%), 17 are a HOLD (9.04%).
Analyst Debjit Chattopadhyay, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 51.31% that have a potential upside of 40.63% achieved within 281 days.
Debjit Chattopadhyay’s has documented 422 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 26-Feb-2026.
Analyst best performing recommendations are on PEPG (PEPGEN LTD).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $22 was fulfilled within 1 day with a profit of $3.15 (12.52%) receiving and performance score of 125.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 11-Mar-2026
$35
$19.47 (125.37%)
$12
8 days ago
(11-Mar-2026)
6/8 (75%)
$17.44 (99.32%)
115
Hold Since 09-Mar-2026
$60
$44.47 (286.35%)
$15
10 days ago
(09-Mar-2026)
4/7 (57.14%)
$42.01 (233.52%)
87
Buy Since 01-Apr-2025
$31
$15.47 (99.61%)
$16
10 days ago
(09-Mar-2026)
7/10 (70%)
$13.01 (72.32%)
89
Hold Since 09-Mar-2026
$35
$19.47 (125.37%)
$11
10 days ago
(09-Mar-2026)
9/11 (81.82%)
$17.01 (94.55%)
347
Hold Since 29-Feb-2024
$9
$-6.53 (-42.05%)
$38
16 days ago
(03-Mar-2026)
8/11 (72.73%)
$-6.63 (-42.42%)
373
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?
